A hybrid technique using bipolar energy in transurethral prostate surgery: A prospective, randomized comparison

Journal of Urology

Volumn 174, Issue 4 I, 2005, Pages 1339-1343

  Tefekli, Ahmet ^a   Muslumanoglu, Ahmet Yaser ^a   Baykal, Murat ^a   Binbay, Murat ^a   Tas, Aytul ^a   Altunrende, Fatih ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Prostate; Prostatectomy; Questionnaires; Transurethral resection of prostate; Urodynamics

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER IRRITATION; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; OPERATION DURATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SCORING SYSTEM; TRANSURETHRAL RESECTION; TREATMENT INDICATION; URETHRA STRICTURE; UROFLOWMETRY; VAPORIZATION;

EID: 24944516197     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000173075.62504.73     Document Type: Article

References (20)

1. Chute, C. G., Panser, L. A., Girman, C. J., Oesterling, J. E., Guess, H. A., Jacobsen, S. J. et al: The prevalence of prostatism: a population based survey of urinary symptoms. J Urol, 150: 85, 1993
2. Holtgrewe, H. L., Mebust, W. K., Dowd, J. B., Cockett, A. T., Peters, P. C. and Proctor, C.: Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol, 141: 248, 1989
3. Donnell, R. F.: Changes in medicare reimbursement: impact on therapy for benign prostatic hyperplasia. Curr Urol Rep, 3: 280, 2002
4. Madersbacher, S., Djavan, B. and Marberger, M.: Minimally invasive treatment for benign prostatic hyperplasia. Curr Opin Urol, 8: 17, 1998
5. Kaplan, S. A.: Minimally invasive alternative therapeutic options for lower urinary tract symptoms. Urology, suppl., 51: 32, 1998
6. Larson, T. R.: Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy. Urology, 59: 12, 2002
7. Botto, H., Lebret, T., Barre, P., Orsoni, J. L., Herve, J. M. and Lugagne, P. M.: Electrovaporization of the prostate with the Gyrus device. J Endourol, 15: 313, 2001
8. Eaton, A. C. and Francis, R. N.: The provision of transurethral prostatectomy on a day-case basis using bipolar Plasma Kinetic technology. BJU Int, 89: 534, 2002
9. Wendt-Nordahl, G., Hacker, A., Reich, O., Djavan, B., Alken, P. and Michel, M. S.: The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol, 46: 586, 2004
10. Larson, B. T., Bostwick, D. G., Corica, A. G. and Larson, T. R.: Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications. J Urol, 170: 12, 2003
11. Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. and Peters, P. C.: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol, 141: 243, 1989
12. Dunsmuir, W. D., McFarlane, J. P., Tan, A., Dowling, C., Downie, J., Kourambas, J. et al: Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate Cancer Prostatic Dis, 6: 182, 2003
13. Shiozawa, H., Aizawa, T., Ito, T. and Miki, M.: A new transurethral resection system: operating in saline environment precludes obturator nerve reflexes. J Urol, 168: 2665, 2002
14. Wang, D. S., Bird, V.G., Leonard, V. Y., Plumb, S. J., Konety, B., Williams, R. D. et al: Use of bipolar energy for transurethral resection of bladder tumors: pathologic considerations. J Endourol, 18: 578, 2004
15. Lagerveld, B. W., Koot, R. A. and Smits, G.: Thermal artifacts in bladder tumors following endoresection: electrovaporization v electrocauterization. J Endourol, 18: 583, 2004
16. Hahn, R. G., Sandfeldt, L. and Nyman, C. R.: Double-blind randomized study of symptoms associated with absorption of glycine 1.5% or mannitol 3% during transurethral resection of the prostate. J Urol, 160: 397, 1998
17. Chinpairoj, S., Feldman, M. D., Saunders, J. C. and Thaler, E. R.: A comparison of monopolar electrosurgery to a new multipolar electrosurgical system in a rat model. Laryngoscope, 111: 213, 2001
18. Dincel, C., Dilek, S. H., Samli, M. M. and Aktepe, F.: Comparing histopathology of materials of transurethral resection with bipolar PlasmaKinetic electroresection and materials of unipolar transurethral resection. Unpublished data
19. Tombal, B., De Visccher, L., Cosyns, J. P., Lorge, F., Opsomer, R., Wese, F. X. et al: Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int, 84: 1015, 1999
20. Bales, G. T., Flynn, T. J., Kynaston, H. G., Golash, A., Hart, A., Kim, H. L. et al: Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia. Tech Urol, 6: 201, 2000